Aim: Long-term, low-level fluoride concentrations in saliva are highly effective in caries prevention and remineralization. The aim of the present two-phased study was to test whether fluoride-releasing lozenges compared to placebo significantly raise salivary fluoride levels above baseline achieved by 1100 ppm fluoride toothpaste in a double-blind, crossover pilot study.
Methods: In phase 1, a four-arm crossover basic study, four participants used one dissolvable lozenge with .25, 0.5, 1 or 1.5 mg fluoride for 1 hour. In phase 2, the three-arm crossover main study, 11 participants used three lozenges per day for 1 hour for 1 week, establishing long-term salivary fluoride levels dissolving 0 (control), 0.5 and 1.5 mg fluoride lozenges. Saliva was collected at baseline; during lozenge use; 5, 15, 30, and 60 minutes later; and early the next morning. Salivary fluoride levels were determined by laboratory diffusion analysis.
Results: In phase 1, 5 minutes after using one lozenge, salivary fluoride levels were above baseline (0.03 ppm), reaching 0.13 ± 0.19 ppm for the 0.25 mg and 0.73 ± 0.75 ppm for the 1.5 mg fluoride lozenge, dropping to baseline after 60 minutes. In phase 2, after 1 week use of 0.5 and 1.5 mg lozenges, respectively, for the 0.5 mg lozenge for 15 minutes and the 1.5 mg lozenge 30 minutes after use, the salivary levels were significantly higher than baseline/control (0.02 ppm). During 1-hour lozenge use, fluoride levels >0.1 ppm were consistently achieved.
Conclusions: Fluoride lozenges achieved elevated salivary fluoride levels during use, but only for short periods after use.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jicd.12336 | DOI Listing |
BMC Oral Health
December 2024
Cerrahpaşa Faculty of Medicine, Department of Medical Biochemistry, Istanbul University-Cerrahpaşa, Istanbul, Turkey.
Background: Saliva contains a variety of biochemical compounds, including antioxidants, and serves as the body's first line of defense against oxidative stress caused by free radicals. The aim of this study was to investigate the effects of dental treatments on salivary oxidative stress biomarkers in children aged 3-5 years with severe early childhood caries (S-ECC) compared to children without caries.
Method: This study was conducted on 20 children aged 3-5 years with severe early childhood caries (S-ECC) and 20 children without caries.
Arch Oral Biol
December 2024
R&D Headquarters, LION Corporation, 7-2-1 Hirai, Edogawa-ku, Tokyo 1320035, Japan.
Objective: This study aimed to compare the effects of a combination of sodium fluoride, soluble calcium, and pyrophosphate (FCaP) versus fluoride alone in inhibiting enamel caries progression.
Design: Different FCaP solutions were prepared, and two were selected for testing (FCaP-1: F = 76 mmol/L, Ca = 7.6 mmol/L, P = 7.
Cureus
November 2024
Department of Orthodontics, Kothiwal Dental College and Research Centre, Moradabad, IND.
Introduction: Dental caries continues to represent one of the most widespread oral health challenges on a global scale, particularly in adolescents. This cross-sectional investigation examines the impact of demographic, clinical, and preventive factors on caries susceptibility and cavitation in children aged six to 15 years, thereby offering a thorough analysis of risk patterns and preventive strategies.
Materials And Methods: This prospective, cross-sectional study was conducted on 2,000 schoolchildren, aged six to 15 years.
J Midlife Health
October 2024
Department of Pathology, Medical College, Navi Mumbai, Maharashtra, India.
Menopause, occurring typically between the ages of 45 and 55 years, marks the end of a woman's reproductive years and is characterized by the cessation of menstruation and a significant decline in estrogen and progesterone production. These hormonal changes impact various aspects of health, including oral health. This review explores the clinical implications of menopause on oral health and outlines preventive strategies.
View Article and Find Full Text PDFClin Oral Investig
November 2024
Department for Biomedical and Neuromotor Sciences, DIBINEM, University of Bologna, Via San Vitale 59, 40125, Bologna, Italy.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!